Recent developments indicate a growing relationship between pharmaceutical companies and telehealth providers, prompting scrutiny from various stakeholders.
Health policy experts and legislators have expressed alarm over these ties, suggesting potential implications for patient care and medication prescriptions.
As the landscape of telehealth evolves, the impact of these partnerships on healthcare practices remains a topic of debate.